Madison, WI: Cannabinoids inhibit cancer cell proliferation and should be clinically tested as chemotherapeutic agents, according to a review published in the January issue of the journal Cancer Research. Last month, investigators at the University of Wisconsin School of Medicine and Public Health reported in the journal Cancer Research that the administration of cannabinoids halts the spread of a wide range of cancers, including brain cancer, prostate cancer, breast cancer, lung cancer, skin cancer, pancreatic cancer, and lymphoma. Busto Arsivo, Italy: Cannabinoids possess anti-tumor activity in glioblastoma cell lines and may offer a new therapeutic option for the treatment of brain cancer, according to a review published in the January issue of the journal Expert Review of Neurotherapeutics. Stockholm, Sweden: Cannabinoids selectively target cancer cells and inhibit tumor growth, according to a forthcoming review to be published in the journal Seminars in Cancer Biology.